| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rallybio Corp | Chief Medical Officer | Option (Right to Buy) | 180K | $126K | $0.70 | Feb 14, 2025 | Direct |
| MBX Biosciences, Inc. | Director | Stock option (right to buy) | 16K | Jun 5, 2025 | Direct | ||
| REATA PHARMACEUTICALS INC | Director | Class A common stock | 0 | $172.03 | Sep 26, 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | $73.68 | Sep 26, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MBX | MBX Biosciences, Inc. | Jun 5, 2025 | 1 | $0 | 4 | Jun 6, 2025 | Director |
| RLYB | Rallybio Corp | Feb 14, 2025 | 1 | $0 | 4 | Feb 19, 2025 | Chief Medical Officer |
| MBX | MBX Biosciences, Inc. | Sep 12, 2024 | 1 | $0 | 4 | Sep 13, 2024 | Director |
| MBX | MBX Biosciences, Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Director |
| RLYB | Rallybio Corp | Feb 15, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Chief Medical Officer |
| RETA | REATA PHARMACEUTICALS INC | Sep 26, 2023 | 6 | $0 | 4 | Sep 26, 2023 | Director |
| RETA | REATA PHARMACEUTICALS INC | Jun 7, 2023 | 4 | $222K | 4 | Jun 9, 2023 | Director |
| RLYB | Rallybio Corp | Feb 6, 2023 | 1 | $0 | 4 | Feb 6, 2023 | Chief Medical Officer |
| RETA | REATA PHARMACEUTICALS INC | Jul 11, 2022 | 6 | $317K | 4 | Jul 12, 2022 | Director |
| RETA | REATA PHARMACEUTICALS INC | Jul 11, 2022 | 0 | $0 | 3 | Jul 11, 2022 | Director |
| RLYB | Rallybio Corp | Feb 7, 2022 | 1 | $0 | 4 | Feb 9, 2022 | Chief Medical Officer |
| RLYB | Rallybio Corp | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Chief Medical Officer |